![PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbaa1feb117d9720c7872debf5f8ac470cd9f5f7/3-Table1-1.png)
PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar
![Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis](https://pbs.twimg.com/media/FnkcjT4aIAEEunv.jpg)
Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis
![Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/9461de2a-ed3f-4139-8675-3cf3d870b2eb/gr1_lrg.jpg)
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology
![A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | Cancer Chemotherapy and Pharmacology A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | Cancer Chemotherapy and Pharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00280-018-3733-2/MediaObjects/280_2018_3733_Fig1_HTML.png)
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | Cancer Chemotherapy and Pharmacology
![Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/table-pdf/big/4881/4881_3600.png)
Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica
![Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ](https://www.bmj.com/content/bmj/381/bmj-2022-074678/F2.medium.jpg)
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ
![Full article: Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system Full article: Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system](https://www.tandfonline.com/cms/asset/21431e78-f2ca-4ea6-ba88-d91fd26af7c1/icmo_a_2285375_f0001_b.jpg)
Full article: Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | PLOS ONE
![Successful therapeutic rechallenge after a severe episode of high dose methotrexate‑induced choreoathetosis: A case report Successful therapeutic rechallenge after a severe episode of high dose methotrexate‑induced choreoathetosis: A case report](https://www.spandidos-publications.com/article_images/mco/11/4/mco-11-04-0354-g02.jpg)
Successful therapeutic rechallenge after a severe episode of high dose methotrexate‑induced choreoathetosis: A case report
Examining the safety of relaxed drug monitoring for methotrexate in response to the COVID-19 pandemic
![Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ](https://www.bmj.com/content/bmj/381/bmj-2022-074678/F1.medium.jpg)